Article info
Primary health care
Systematic review
Some evidence that continuous subcutaneous insulin infusion for type I diabetes improves glycaemic control compared with multiple daily injections, but few trials have compared CSII with MDI using newer insulin analogues
- Correspondence to Phyllis Wolff-McDonagh
Diabetes and Endocrinology Center of Suffolk, 285 Sills Road, East Patchogue, NY 11772 USA; pwolffnp{at}optonline.net
Citation
Some evidence that continuous subcutaneous insulin infusion for type I diabetes improves glycaemic control compared with multiple daily injections, but few trials have compared CSII with MDI using newer insulin analogues
Publication history
- First published December 9, 2010.
Online issue publication
December 15, 2010
Article Versions
- Previous version (9 December 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions